BioMedNewsBreaks – Galileo Life Sciences Inc. (MDRM) Issues Telehealth Progress Update

June 17, 2021 12:33:51
Galileo Life Sciences (OTC: MDRM), a company strategically focused on the telehealth and telemedicine industry, today provided an update on its progress in providing next-generation telehealth services. Innovations in telehealth have enabled health care providers with superior technology, allowing them to diagnose, treat and monitor the state of their patients with greater efficiency. However, video conferencing, the key tool in most telehealth technologies, limits the ability of physicians to check the patients’ vitals. Galileo Life Sciences, through its partnerships with various technology organizations, has established a unique platform that is connected with medical devices, which enables physicians to check patients’ vitals in real time. “I strongly believe that establishing a chain of virtual clinics as the backbone of our offering will uniquely position Galileo as a full-service telehealth company,” said Galileo’s Medical Director Gilbert Sharpe. “We are able to offer patients the option to seek treatment via a video call, attend a virtual clinic for a more thorough examination, or request a house call by one of our nurse practitioners who will bring the doctor to you via our home care devices. The clinics will be located in pharmacies or near pharmacies thus providing a patient a one-stop doctor’s visit to get the prescription filled.” To view the full press release, visit About Galileo Life Sciences Inc. Galileo Life Sciences is a company strategically focused on the telehealth and telemedicine industry and is planning to offer services on a global scale. The company is dedicated to offering the most robust telehealth platform incorporating artificial intelligence (“AI”) and internet of things (“IOT”) so that anyone can get access to quality health care regardless of location and financial status. The company is committed to providing health care to those who cannot afford it. The Galileo Smart Clinics with integrated medical devices make this company unique, separate from the rest in the field. With Galileo Life Sciences, physicians can get direct access to the patient’s vitals and examine the patient in real-time without affecting the quality of care. For more information, visit About BioMedWire BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only) For more information please visit Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: BioMedWire (BMW) San Francisco, California 415.949.5050 Office BioMedWire is part of the InvestorBrandNetwork